Dental considerations for the patient with diabetes by Martí Álamo, Silvia et al.
e25
J Clin Exp Dent. 2011;3(1):e25-30.                                                                  Considerations diabetic patients.
Journal section: Oral Medicine and Pathology                                                         doi:10.4317/jced.3.e25
Publication Types: Review
Dental considerations for the patient with diabetes
 
Silvia Martí Álamo 1, Yolanda Jiménez Soriano 2, Mª Gracia Sarrión Pérez 3
1 Dentist.
2 Assistant Professor Doctor. Department of Stomatology. Medicine and dentistry faculty. Valencia University.
Correspondence:
San Vicente mártir st., 102, 20
46007 Valencia
E- mail: silviamartialamo@hotmail.es
Received: 11/06/2010
Accepted: 21/11/2010
Abstract 
Diabetes mellitus (DM) is one of the most frequent pathologies that dentists encounter, due to its high prevalence 
worldwide. It is diagnosed by the repeated obtaining of fasting plasma glucose levels of 126 mg/ dl or higher, or 
glycosylated hemoglobin of 6’5% or higher. Diabetes (especially if it is not well controlled) brings with it a greater 
risk of periodontal disease, which is the most frequent complication. On the other hand, the possible influence of 
periodontal disease on glycemic control is still not well established. Other reported manifestations are xerostomia, 
sialadenosis and burning mouth syndrome. With regard to dental caries, oral lichen planus and candidosis, recent 
studies have not revealed a significantly higher incidence in these patients.
For dental treatment, the type of diabetes suffered, the treatment given for the disease, and the glycemic control sta-
tus (using the glycosylated hemoglobin test) should be known. Patients should receive short morning appointments 
to reduce stress. The dentist has to be aware of the possible occurrence of an acute complication (hypoglycemia 
or hyperglycemia). Furthermore, these patients suffer from delayed wound healing and major susceptibility to 
infections.
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Introduction
Diabetes mellitus (DM) is one of the most frequent pa-
thologies that dentists encounter. Its clinical importance 
springs from the possible occurrence of acute complica-
tions, whose severity could mean an immediate risk for 
the diabetic patient’s life and require urgent diagnosis 
and treatment (1).
DM includes a group of diseases characterized by im-
paired action or secretion of insulin, or both. There are 
four etiologic types of diabetes, although the most fre-
quent are type 1 (90%) and 2 (5- 10%) (2). Prevalence of 
diabetes in adults worldwide was estimated to be 4% in 
1995, and is predicted to rise to 5’4% by the year 2025. 
The countries with the largest number of people with 
diabetes are India, China and the U.S. In developing 
countries, the majority are in the age range of 45–64 
years. In the developed countries, the majority of people 
with diabetes are aged 65 years. There are more women 
than men with diabetes (3).
Poorly controlled diabetes could lead to complications 
that may even be life- threatening. Long- term compli-
cations include: retinopathy, nephropathy, autonomic 
neuropathy, peripheral neuropathy and cardiovascular 
disease (2, 4).
The dentist plays a major role with other members of the 
health team in helping a patient maintain glycemic con-
trol by achieving optimal oral health; and by referring 
undiagnosed patients with complications suggestive of 
diabetes to physicians for further evaluation (5).
Objectives
The objectives of this paper are: firstly, to do a review of 
literature about diabetes mellitus, and the repercussions 
of the disease in dentistry; and, secondly, to summarize 
the management strategies that can be put into practice 
in the dental office to treat these patients.
Material and Methods
For this review, we selected articles from the PubMed- 
Medline database. We searched for them using key words 
controlled by MeSh, all of them referred to diabetes, its 
complications and considerations for the dental manage-
ment. The following limits were utilized: articles written 
in Spanish or in English and published in the 1993- 2010 
period. A total of 25 articles were chosen: 8 reviews of 
literature (1 of them being a systematic review); 7 trans-
versal studies; 2 meta- analysis; 3 panels of experts; 2 
clinical cases; 1 randomized clinical assay; 1 letter to the 
editor and 1 case- control study.
Results
Oral manifestations. Periodontal disease is the most fre-
quent oral complication of diabetes, as reported by Löe 
(6) in 1993, who referred to it as “the sixth complication 
of diabetes mellitus” (the other five complications are: 
retinopathy, nephropathy, microvascular disease and pe-
ripheral vascular disease) (4).
A patient with poorly controlled diabetes has a major risk 
of developing periodontal disease (5, 7), which will start 
as gingivitis and gradually, if the glycemic control is de-
ficient, this may progress to an advanced periodontitis. 
Diabetic children and adults without proper control of 
their diabetes show a tendency to present higher gingival 
indexes. Besides, several studies have demonstrated that 
patients with poorly controlled type 1 DM have more ad-
vanced and severe periodontal disease than patients with 
an adequate glycemic control; this could be due to the 
association found between poorer glycemic control and 
elevated gingival crevicular fluid interleukin-1β (7). 
Several mechanisms have been proposed which may 
explain how diabetes produces alterations in the organs 
and tissues, including the periodontium. First studies 
demonstrated that the advanced glycation end- products 
(AGE) synthesized due to hyperglycemia, can convert 
macrophages into cells with a destructive phenotype, 
producing high levels of interleukin-1β, interleukin 6 
(IL-6) and tumour necrosis factor- α (TNF-α). Moreover, 
AGE have the capacity to increase the endothelium per-
meability and express high levels of molecular adhesion 
receptors. These changes could explain the greater sus-
ceptibility to infections and the delayed wound healing 
in diabetic patients (8). This depressed immune response 
could explain why it may not be possible to eradicate 
periodontal infection totally in diabetics after conven-
tional periodontal therapy. This might be one of the rea-
sons why antibiotics may be suggested with mechanical 
therapy for diabetic patients, especially for uncontrolled 
cases (7). By contrast, in trying to determine the capaci-
ty of periodontal disease to adversely affect the control 
of diabetes by influencing gylcemia levels, it has been 
hypothesized that chronic low grade inflammations such 
as this might result in insulin resistance (9).
Some studies report that specific treatment of periodon-
tal disease in diabetic patients may improve their glyce-
mic control. Nevertheless, the evidence currently availa-
ble does not provide sufficient information on which to 
confidently base any clinical recommendations (10, 11, 
12). This has motivated the preparation of a randomized 
and controlled trial which will provide evidence- based 
recommendations for clinicians (DIAPERIO trial, who-
se definitive results will be published in 2013) (12).
The relationship between DM and dental caries has been 
studied, but it has not been possible to establish a clear 
association between these conditions. The results ob-
tained vary considerably depending on the study; some 
of them found a higher prevalence of caries in diabetic 
patients (13, 14), some found lower (15), while other re-
ported no difference (16).
Diabetic patients sometimes complain of having a dry 
mouth (xerostomia), which can be due to thirst, a fre-
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could be salivary dysfunction, immunosuppression and 
high salivary glucose levels (5). However, it is widely 
recognized that high salivary glucose levels in diabetic 
patients favour yeast growth (21).
DM is considered one of the systemic causes of burning 
mouth syndrome (BMS). The latest studies of this pa-
thology suggest that the cause is a peripheral neuropathy 
(16). Moore et al. (22), in a study carried out on 371 adult 
patients with type 1 DM, concluded that the majority of 
diabetic patients with BMS were mainly women who 
had developed a peripheral neuropathy due to their DM. 
This, and other similarities found between BMS and the 
peripheral neuropathy, suggests that a neuropathic pro-
cess could be the underlying cause of BMS (22). 
An association between DM and oral lichen planus has 
been described in literature, but has not been seen con-
sistently in all populations of individuals with diabetes 
(16). For that reason, there appears to be no relationship 
between lichen planus and diabetes mellitus (5).
Loss of joint flexibility and increased stiffness are com-
mon clinical findings in DM. At the extreme end of these 
manifestations, they affect the extra- articular tissues, re-
sulting in significant deformity and inflexibility of joints 
–“diabetic cheiroarthropathy”-. Temporomandibular 
joint dysfunction has not been studied specifically in 
diabetic patients, but since DM is a metabolic disorder, 
all joints may be susceptible (4). The association of os-
teoporosis with type 1 DM is well- established. But for 
patients with type 2 DM this relationship is still unclear, 
although there is an increased risk of fracture attributed 
to falls due to hypoglycemia (4).
Dental considerations. Prior to dental treatment, the 
dentist must obtain a complete medical history, which 
indicates the type of diabetes suffered and complica-
quent manifestation of diabetes (16). In a study carried 
out on 40 adult type 2 diabetic patients, it was possible 
to assess objectively, using scintigraphy of the salivary 
glands, that there was an actual alteration in the salivary 
glands’ function (17). A different study revealed an alte-
ration in the secretory capacity of the salivary glands in 
adults with poorly controlled diabetes, compared to well 
controlled diabetic patients and nondiabetic patients, 
although they did not refer xerostomia (18).
Sialadenosis is an asymptomatic bilateral parotid gland 
enlargement quite common in diabetes (especially type 
2). It has also been reported in alcoholism with liver pa-
thology, and in chronic malnutrition (19). It is considered 
a metabolic or degenerative pathology (not inflammatory 
or tumoral). The most accepted etiopathogenic theory 
posits the existence of a disturbance in the autonomic 
sympathetic innervation, that leads to a dysregulation 
of protein synthesis and/ or its secretion. Cytoplasmic 
swelling develops from engorgement of intracytoplas-
mic zymogen granules. As a result, the parotid’s acini, 
which normally measure 40 µm in diameter, increases to 
as much as 100 µm. This enlargement causes the clini-
cally visible glandular hypertrophy (19). It has also been 
reported that parotid enlargement in diabetic patients 
could be a consequence of lipid infiltration, due to the 
alteration in the lipidic metabolism in diabetes (20). In 
any case, sialadenosis does not require treatment (19).
In diabetic patients, the presence of Candida species in 
the oral cavity is greater than in non diabetic patients; 
however, candidal infection –candidosis- may not be sig-
nificantly higher, not even in individuals with a poorly 
controlled diabetes. The mechanism by which diabetes 
predisposes a high oral presence of Candida is not yet 
established (21), although it is believed that the reasons 
CRITERIA FOR THE DIAGNOSIS OF DIABETES
MEASUREMENT DIAGNOSTIC VALUES FOR DIABETES CHARACTERISTICS
Glycosylated hemoglobin 
(HbA1c)
≥ 6.5%
The test should be performed in a laboratory 
using the standarized method. It reflects average 
blood glucose levels over a 2- to 3-month period 
of time
Fasting plasma glucose ≥ 126 mg/ dl (7.0 mmol/ l) Fasting is defined as no caloric intake for 8 
hours
Postprandrial plasma glucose
(2 hours after caloric intake)
≥ 200 mg / dl (11.1 mmol/ l)
The test should be performed as described by 
the World Health Organization, using a glucose 
load containing the equivalent of 75g anhydrous 
glucose dissolved in water
Random plasma glucose ≥ 200 mg / dl (11.1 mmol/ l)
Table 1. Criteria for the diagnosis of diabetes (American Diabetes Association, 2010) (2)
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tions, the treatment received and the status of diabetes 
control. The recent consensus of the American Diabetes 
Association and the European Association for the Study 
of Diabetes (2009) (23) advocate glycated hemoglobin 
as the main parameter to assess the metabolic control. 
As a rule, a HbA1c <7%, a preprandial glycemia of 
70- 130 mg/ dl and a postprandial glycemia <180 mg/
dl are indicative of good metabolic control. The well- 
controlled diabetic patient can be treated similarly to a 
nondiabetic patient, preferably receiving short morning 
appointments to reduce stress. They must not fast, in or-
der to prevent hypoglycemia (1).
Within the sphere of the dental office, we can consider 
two kinds of complications in these patients. First, the 
acute complications -which can break out during the 
appointment- which are hypoglycemia and hypergly-
cemia (1). With respect to the chronic complications of 
diabetes of interest in this case, there are some systemic 
(like neuropathy, nephropathy and cardiovascular di-
seases) (1, 2, 4), and some affecting the stomatognathic 
area, like periodontal disease (6, 8), sialadenosis (18), 
burning mouth syndrome (17), and osteoporosis and 
possible dysfunction of the temporomandibular joint 
(5). We should be aware of the increased susceptibili-
ty of these individuals to infections and delayed wound 
healing (9).
Dental management of diabetes. When a dental treatment 
is going to be performed, some considerations must be 
taken into account. These would be appreciably different 
depending on the type of diabetes suffered. In this paper 
we analyze type 1 and 2 diabetes, the most prevalent 
forms.
▪ Type 1 diabetic patients undergoing a dental procedure 
(1):  follow the considerations previously described.
- Non- invasive dental procedures: well- controlled 
patients can be treated similarly to nondiabetic indivi-
duals. Be aware of the increased susceptibility of these 
patients to infections and delayed wound healing. In 
poorly controlled patients, delay the dental treatment 
if possible until they have achieved good metabolic 
control.
- Invasive dental procedures: patients should ask their 
doctor for instructions concerning their medication 
(normally, if they have metabolic stability, they should 
take half their daily dose of insulin the morning of the 
treatment; then, after the intervention, the whole dose 
should be taken with a supplement of rapid-acting 
insulin). Blood glucose should be measured preope-
ratively. If it is between 100 and 200 mg/dl, the in-
vasive dental procedure can be performed. If blood 
glucose is >200 mg/ dl, an intravenous infusion of 
10% dextrose in half- normal saline is initiated, and 
rapid- acting insulin is administered subcutaneously. 
If the treatment lasts more than 1 hour, blood glucose 
should be measured hourly. If blood glucose is >200 
mg/ dl, rapid acting- insulin should be administered 
subcutaneously.
Type 1 DM is considered a risk factor with regard to 
suffering infection. For that reason, when invasive 
dental procedures are going to be performed (as in-
tra ligamentous anesthesia, teeth extractions, biopsies, 
etc.), the usual guidelines for the antibiotic prophylaxis 
should be followed (24).
▪ Type 2 diabetic patients undergoing a dental procedure 
(1):  follow the considerations previously described.
- Non- invasive dental procedures: people who control 
their disease well by diet and exercise require no spe-
cial perioperative intervention. As in type 1 diabetic 
patients, be aware of their susceptibility to infections 
and delayed wound healing. In poorly- controlled pa-
tients, delay the dental treatment if possible until they 
have achieved good metabolic control.
- Invasive dental procedures: patients should ask their 
doctor for instructions regarding their medication 
(normally, those patients being treated with oral hypo-
glycemic agents should take their normal dose in the 
morning and eat their regular diet).
Acute complications. Hypoglycemia is the major issue 
that confronts dental practitioners when treating diabe-
tic patients, particularly if patients are fasting (4). The 
clinical presentation of hypoglycemia is very similar 
to hyperglycemia. If in doubt, it should be treated as a 
hypoglycemia. The characteristics and treatment of this 
complication are showed in Table 2 (4).
Hypoglycemia usually appears in response to the stress 
experienced before, during or after the treatment, and has 
been shown to cause a significant increase in periopera-
tive morbidity and mortality (1). The stress response is 
characterized by acute metabolization of carbohydrates, 
proteins and fats to provide increased levels of glucose, 
which is necessary as a major fuel source to the vital 
organs. In addition, resistance to the effects of insulin 
increase (1). There are no specific guidelines regarding 
which levels of hyperglycemia are dangerous or how it 
should be managed before or during the procedure, so 
if the patient is conscious and can follow other instruc-
tions, it is prudent to continue with the treatment (4).
Chronic complications. The possible cardiovascular 
complications of diabetes should be properly assessed 
before dental treatment. Autonomic neuropathy can pre-
dispose to orthostatic hypotension, respiratory arrest or 
hemodynamic instability. If the patient has renal compli-
cations, a dose adjustment of the drugs should be perfor-
med, using the creatinin clearance (1). It is recommen-
ded to associate antibiotic treatment when  mechanical 
periodontal treatment is performed, and also administer 
an antibiotic prophylaxis (7, 25). Osteoporosis present 
in type 1 DM requires great care when performing sur-
gery, in order to prevent iatrogenic fractures (4). Due to 
the delayed healing response in diabetic patients (8, 25), 
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implant therapy is still controversial and at the moment, 
there is a lack of definitive guidelines. In any case, the-
se individuals could be candidates for the placement of 
dental implants if they have good control of their meta-
bolism. There is general agreement in advocating the use 
of prophylactic antibiotics in diabetic patients (25).
Conclusions
Periodontal disease is the main oral clinical manifesta-
tion in diabetic patients. Furthermore, burning mouth 
syndrome, the sensation of a dry mouth and and sialade-
nosis have been attributed to the disease.
With these patients, we should be aware of their in-
creased susceptibility to infections and delayed wound 
healing. Well- controlled diabetics can be treated in the 
dental office similarly to nondiabetic patients, but mor-
ning appointments are preferable, and patients should be 
instructed not to fast, in order to reduce the risk of the 
occurrence of hypoglycemia.
References
1. Bergman SA. Perioperative management of the diabetic patient. 
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:731-7. 
2. American Diabetes Association. Diagnosis and classification of dia-
betes mellitus. Diabetes Care. 2010;33:62-9.
3. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-
2025: prevalence, numerical estimates, and projections. Diabetes Care. 
1998;21:1414-31.
4. Kidambi S, Patel SB. Diabetes mellitus: considerations for dentistry. 
J Am Dent Assoc. 2008;139:8S-18S.
5. Vernillo AT. Dental considerations for the treatment of patients with 
diabetes mellitus. J Am Dent Assoc. 2003;134:24S-33S.
6. Löe H. Periodontal disease. The sixth complication of diabetes me-
llitus. Diabetes Care. 1993;16:329-34.
7. Tan WC, Tay FB, Lim LP. Diabetes as a risk factor for periodontal 
disease: current status and future considerations. Ann Acad Med Sin-
gapore. 2006;35:571-81.
8. Kaur G, Holtfreter B, Rathmann W, Schwahn C, Wallaschofski H, 
Schipf S, et al. Association between type 1 and type 2 diabetes with pe-
riodontal disease and tooth loss. J Clin Periodontol. 2009;36:765-74.
9. Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Reca-
sens M, Ricart W. Burden of infection and insulin resistance in healthy 
middle-aged men. Diabetes Care. 2006;29:1058-64.
10. Darré L, Vergnes JN, Gourdy P, Sixou M. Efficacy of periodontal 
treatment on glycaemic control in diabetic patients: A meta-analysis of 
interventional studies. Diabetes Metab. 2008;34:497-506.
11. Janket SJ, Wightman A, Baird AE, Van Dyke TE, Jones JA. Does 
periodontal treatment improve glycemic control in diabetic patients? A 
meta-analysis of intervention studies. J Dent Res. 2005;84:1154-9.
12. Vergnes JN, Arrivé E, Gourdy P, Hanaire H, Rigalleau V, Gin H, et 
al. Periodontal treatment to improve glycaemic control in diabetic pa-
tients: study protocol of the randomized, controlled DIAPERIO trial. 
Trials. 2009;10:65.
13. Miralles L, Silvestre FJ, Hernández-Mijares A, Bautista D, Llam-
bes F, Grau D. Dental caries in type 1 diabetics: influence of systemic 
factors of the disease upon the development of dental caries. Med Oral 
Patol Oral Cir Bucal. 2006;11:E256-60.
14. Arrieta-Blanco JJ, Bartolomé-Villar B, Jiménez-Martínez E, 
Saavedra-Vallejo P, Arrieta-Blanco FJ. Bucco-dental problems in pa-
tients with Diabetes Mellitus (I): Index of plaque and dental caries. 
Med Oral. 2003;8:97-109.
15. Siudikiene J, Machiulskiene V, Nyvad B, Tenovuo J, Nedzelskiene 
I. Dental caries and salivary status in children with type 1 diabetes 
mellitus, related to the metabolic control of the disease. Eur J Oral Sci. 
2006;114:8-14.
IDENTIFICATION AND TREATMENT OF HYPOGLYCEMIA
IDENTIFICATION
Symptoms Signs
◦ Shakiness
◦ Anxiety
◦ Increased sweating
◦ Hunger
◦ Tremors
◦ Tachycardia
◦ Altered consciousness (lethargy and obtundation or per-
sonality change)
◦ Blood glucose level: < 60 mg/dl
TREATMENT
Conscious patient Unconscious patient
◦ Administer 15 mg of simple carbohydrates
◦ Repeat finger- stick glucose test in 15 minutes:
◦ Blood glucose level  > 60 mg/dl: patient should be 
asked to eat or drink (for example, a sugar-sweetened 
beverage)
◦ Blood glucose level  < 60 mg/dl: repeat treatment of 
15 g of simple carbohydrates and check blood glucose 
in 15 minutes. Continue until achieving a blood gluco-
se level > 60mg/ dl
◦ Ask the patient to notify his/ her physician
With intravenous access:
◦ Administer 5 to 25 g of 50% dextrose immediately
◦ Notify the patient’s physician
Without intravenous access:
◦ Apply glucose gel inside the mouth in a semiobtund pa-
tient or treat with 1 mg of glucagon intramuscularly or 
subcutaneously
◦ Repeat the blood glucose test in 15 minutes
◦ Establish intravenous access and notify the patient’s 
physician
Table 2. Identification and treatment of hypoglycemia in the dental office.
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